Compare AKR Corporindo Tbk (AKRA) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AKR Corporindo Tbk vs Tempo Scan Pacific Tbk. — how do they compare? AKR Corporindo Tbk trades at Rp1,400 (market cap 28T, 6.58M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: AKR Corporindo Tbk is far larger — about 2.2× Tempo Scan Pacific Tbk.'s market cap, and AKR Corporindo Tbk is more actively traded (6.58M versus 235.2K). Which is the better fit depends on your goals.
| AKRA | TSPC | |
|---|---|---|
Market Cap | 28T | 12.58T |
Volume | 6.58M | 235.2K |
Lot | 65.84K | 2.35K |
Turnover | 9.25B | 649.94M |
Average Price | 1,405.14 | 2,763.37 |
Value | 9.25B | 649.94M |
Indicative Equilibrium Price | 1,400 | 2,780 |
Indicative Equilibrium Volume | 1.94K | 9 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AKR Corporindo Tbk
PT AKR Corporindo Tbk was established in Surabaya on November 28, 1977 based on the Notarial Deed No. 46 of Sastra Kosasih, S.H., which was amended by Notarial Deed No. 26 of the same notary dated April 12, 1978 . In 2004, the Company changed its name from PT Aneka Kimia Raya Tbk to PT AKR Corporindo Tbk. PT Aneka Kimia Raya is the largest chemical distributor in Indonesia. The Company is dominantly positioned within the industry, distributing more than 40 chemical products. The Company is foreign investment.
Read more on AKRA →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
